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Abstract
Background: E. coccinae (SIMS) G. (Asteraceae) is an annual plant commonly found throughout the plain of the
Central Africa and widely used in Cameroonian folk medicine for the treatment of fever and convulsions in children.
We previously reported that the methanolic extract of this plant improved spatial memory. However no underlying
mechanism was explored. The present study was undertaken to investigate the effects of the hydroalcoholic extract
of Emilia coccinae on memory in scopolamine treated rats and to propose possible mechanisms of action.
Methods: Novel object recognition and Y-maze paradigm were used to test memory while oxidative profile, AChE
and ACh level of the whole brain were assessed to outline the mechanism of nootropic activity of the extract.
200 and 400 mg/kg of the extract were chronically administrated during 14 consecutive days in separate groups of
scopolamine intraperitoneal treated rats (1.5 mg/kg).
Results: The hydroalcoholic extract of Emilia coccinae (HEEC) at the dose of 200 mg/kg significantly improved the
memory of rats and reversed the amnesia induced by scopolamine. In addition, we showed that this extract is
decreasing the acetyl cholinesterase activity while also increasing the acetylcholine levels in the brain. HEEC
(200 and 400 mg/kg) significantly increased antioxidant enzyme activities (SOD, GSH and CAT) and reduced lipid
peroxidation (MDA level) in the rat whole brain homogenates.
Conclusions: Taken together, our results suggested that the hydroalcoholic extract of Emilia coccinae ameliorated
the cognitive dysfunction in scopolamine treated rats through the blockage of the oxidative effect of scopolamine
and inhibition of AChE activity.
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Background
Alzheimer’s disease (AD) is a neurodegenerative disease
related to cognitive and behavioral impairments, charac-
terized by loss or decline in memory and severe cognitive
impairments.
Older age, genetic predisposition, other acquired med-
ical conditions, stress and emotions are factors that may
contribute to various deficiencies observed in AD such
as memory loss, impaired learning, and dementia or to
more ominous threats like Parkinson’s and Alzheimer’s
diseases [1, 2].
To date, the main cause of AD remains unclear, but
it is considered that the β-amyloid and tau protein
aggregation, reduced acetylcholine (ACh), and glutamater-
gic deficit are regarded as principal pathogenesis of AD
[3]. Recent studies have speculated that free radicals pro-
duced during oxidative stress and/or inflammatory pro-
cesses are also pathologically important in AD [4].
Accumulation of free radical damage and alterations in
the activities of antioxidant enzymes such as superoxide
dismutase and catalase have been observed in the central
nervous system of AD patients [5]. Moreover, in AD and
mild cognitive impairment brains, the increased oxidative
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damage to lipids and proteins and the decline of glutathi-
one and antioxidant enzyme activities correlate with the
severity of the disease, suggesting that oxidative stress
may be one of the alterations that occur during the initi-
ation and development of AD [6, 7].
In the last decades many studies have been performed
in order to develop an efficient drug for AD therapy.
However, very few of them have obtained the final
approvals in most countries.
Unfortunately, none of the drugs can reverse nor stop
the course of the disease. In this way, most of these sub-
stances, which are used for the symptomatic treatment
of AD since 1990, are cholinesterase inhibitors that pro-
long the acetylcholine (ACh) availability after it is re-
leased from cholinergic nerve endings, through the
inhibition of acetylcholinesterase (AChE). However, non
selectivity of these drugs, their limited efficacy, and poor
bioavailability, adverse cholinergic side effects in the per-
iphery, narrow therapeutic ranges, and hepatotoxicity
are among the several limitations to their therapeutic
success [8, 9].
Moreover, the drugs could exert several important side
effects including diarrhea, nausea, insomnia, muscles
cramps, vomiting, fatigue and loss of appetite [10]. Thus,
considering the fact that the management of AD can be
a major challenge for the health care systems, all around
the globe many research are now undertaken in order to
valorize phytopharmaceutical alternatives approaches
which is widely available and accessible at low costs. In
this way, numerous plants like Areca catechu [11], Bos-
wellia papyrifera [12] or Malva parviflora [13], have
been reported to treat cognitive disorders; learning and
memory disorders, which are commonly observed in
AD. Thus, there is a growing interest in the use of plant
extract to improve leaning, memory and general cogni-
tive function, with a large number of reviews highlight-
ing the benefits of some phytochemicals as brain
function modulators [14, 15]. Moreover, in one of our
previous studies, we reported the in vitro antioxidant ef-
fects of Emilia coccinae, which could have been corre-
lated also with some facilitating effects of the same
extract on an animal model of anxiety and depression
[16]. In that study, the standardized methanolic extract
of Emilia coccinae significantly increased the number of
open arm entries and time spent in the open arms of
the elevated plus maze test and was as effective as
Imipramine in inducing shortening of immobility time
in forced swimming test.
Phytochemical analysis revealed that the dry leaves
contained 863.04 ± 5.42 mg of GAE/100 g of dry ma-
terial, which represents a very good content of total
phenolics compounds while the total reducing power
was about 4.71 ± 0.04 g of Vit C equivalent/100 g of
dry material.
Some studies hypothesized that the presence of depres-
sion or anxiety would hinder some aspects of memory
performance. Depression, when compounded by anxiety,
has not only an adverse effect on immediate recall and
amount of acquisition, but also on the retrieval of newly
learned information [17], illustrating the effects of co-
morbidity on memory and learning. It thus appeared
reasonable for us to explore the effect of this extract
with both anxiolytic and antidepressant activities in
short-term memory.
In fact, E. coccinae (SIMS) G. (Asteraceae) is an annual
plant commonly found throughout the plain of the Cen-
tral Africa and in dry area up to 2000 m altitude in the
eastern Africa [18]. This species belongs to the genus
Emilia represented by about 100 species, with 50 of
them found in Africa [18]. In the folk African traditional
medicine, this plant is used for the treatment of fever
and convulsions in children [19]. The dry leaves are used
for the treatment of wounds, sores and sinusitis ulcer,
ringworm [20]. In addition, in some tribe in the western
part of Cameroon, the infusion of the dry leaves of this
plant is used as a potent sedative and restorative.
Therefore, considering the promising behavioral result
obtained with this specie, the modest cognitive benefit
offered by the available treatments with some time the
severe side effects, we decided to investigate the effect
of chronic administration of the hydroalcoholic extract of
E. coccinae in a experimental model of cognitive im-
pairment in rats, as induced by scopolamine, an anti-
muscarinic drug.
Methods
Plant material and extraction
Fresh leaves of E. coccinae were harvested in February
2013 at Etoug Ebe in the Centre Region of Cameroon
and authenticated at the National Herbarium-Yaoundé,
where the voucher specimen was conserved under the
reference number 6297/HNC. The leaves were washed
and dried at room temperature (24–26 °C during 10 days)
and pulverized into a coarse powder using a suitable
grinder. The powder was stored in a dark and airtight
container and kept in −30 °C until further analysis.
Hydroalcoholic extraction
The preparation of the plant extract was as described by
Haque et al. [21]. Briefly, 150 g of powdered material
was placed in a clean, flat-bottomed glass container and
soaked in 1.5 L of methanol/water (70/30, V/V). Then the
extraction was carried out by using an Ultrasonic Sound
Bath accompanied by sonication (45 °C, 25 min). The en-
tire mixture underwent a coarse filtration through white
cotton material. The extract obtained was filtered through
Whitman filter paper (Bibby RE200, Sterilin Ltd., UK).
The solution was then concentrated using a rotavapor in
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high vacuum up to 60 °C. The filtrate was later frozen and
lyophilized to obtain the hydroalcoholic (27.90 g) extracts.
Experimental animals
Male Wistar albino rats (n = 30), weighing 100–180 g at
the beginning of the experiment, were obtained from the
Laboratory of Phytopharmacology (LAPHYPHA) of the
University of Dschang, Cameroun. The animals were
housed in polyacrylic cages (6 animals/cage) and main-
tained in a temperature and light-controlled room (25 ±
2 °C, a 12-h cycle). The animals were acclimatized to
laboratory condition for 7 days before the start of experi-
ment. Prior to and after treatment, the animals were
fasted for 12 and 7 h, respectively. However, all animals
were allowed to drink water ad libitum. Rats were
treated in accordance with the guidelines of the Camer-
oonian bioethics committee (reg N°.FWA-IRB00001954)
and in accordance with NIH- Care and Use of Labora-
tory Animals manual (8th Edition). The present study
was approved by the Ethic Committee of the Faculty of
Sciences of the University of Maroua (Ref. N°14/0261/
Uma/D/FS/VD-RC), Cameroon. Efforts were also made
to minimize animal suffering and to reduce the number
of animal used in the experiment. Each animal was
tested in only one behavioral test. The experiments were
performed in the morning (8–12 h), and the light level
in the experimental room was 200 lux.
Chemicals
Scopolamine, chloral hydrate, acetylthiocholine iodide, 5,
5-dithiobis (2-nitro-benzoic acid) (DTNB), 2-thiobabituric
acid (TBA), Piracetam were purchased from Sigma–
Aldrich, USA. All drugs and extracts were freshly
prepared in saline on the day of the experiments. Scopol-
amine and piracetam was administered intraperitoneally
(i.p.) to the rats while the extract was administered
by gavage (per os, p.o.). Control animals received oral
administration of 10 ml/kg body of the vehicle.
Animal treatments
Rats were randomly allocated into five groups of 6 animals
each as follows: Group I received saline solution and
served as normal control. Group II received scopolamine
(1.5 mg/kg) administered intraperitoneally and served as
model group. Both groups received normal saline for
14 days. Groups III received piracetam (150 mg/kg)
through intraperitoneal injection (i.p.). Group IV and V
received respectively HEEC at the doses of 200 and
400 mg/kg, by gavage respectively for 14 days. The doses
were fixed based on earlier studies on the hydroalcoholic
extract of Emilia coccinae extract in our laboratory.
Scopolamine (1.5 mg/kg) as a disease inducer was
administered as a single dose 30 min after drugs adminis-
tration through intraperitoneal injection (i.p.) route to all
the groups except normal control group. The same pro-
cedure was carried out on days 1, 4 and 8 because of the
transient effect of the scopolamine on memory impair-
ment [22, 23]. Behavioral testing was done on days 8 and
day 14 following extract administration, 30 min after sco-
polamine injection. The aforementioned dosage and the
duration of treatment were selected following a screening
studies and previously published reports regarding Emilia
coccinae biological effects [16] (see Table 1).
Behavioral evaluation
The animals’ behavioral activities were tracked and re-
corded using trial version of ANY-maze 4.9 behavioral
software.
Y-Maze test
Y-maze analysis has been shown to be a reliable, nonin-
vasive test to determine cognitive changes in Wistar rat
through the measurement of the spontaneous alterna-
tion behavior in the Y-maze task [24].
The maze used in the present study consisted of three
arms (35 cm long, 25 cm high and 10 cm wide) and an
equilateral triangular central area.
All animals were tested in a randomized order at the
start and end of the experimental protocol. Rats were
treated once daily whit the hydroalcoholic extract of E.
coccinae leaves (200 and 400 mg/kg, per os), piracetam
(150 mg/kg, i.p.), or saline (10 ml/kg; per os) during 14
consecutive days. Thirty minutes after the aforemen-
tioned drug had been administrated; rats were placed at
the end of one arm and allowed to move freely through
the maze for 8 min. The time limit in Y-maze test was
8 min, and every session was stopped after 8 min. An
arm entry was counted when the hind paws of the rat
were completely within the arm. Spontaneous alterna-
tion behavior was defined as three consecutive entries in
three different arms (i.e. A, B, C or B, C, A, etc.). The
percentage alternation score was calculated using the
following formula: Total alternation number/Total num-
ber of entries minus 2) x 100. Furthermore, the total
number of arm entries was used as a measure of general
activity of the animals. The maze was wiped clean with
Table 1 Experimental design
Group Treatment Dose (mg/kg)
I Normal control treated
with saline solution
-
II Negative control group
treated with scopolamine
1.5 mg/kg, i.p
III Piracetam + Scopolamine 150 mg/kg + 1.5 mg/kg, i.p
IV Extract low dose +
Scopolamine
200 mg/kg, p.o. + 1.5 mg/kg, i.p
V Extract high dose +
Scopolamine
400 mg/kg, p.o. + 1.5 mg/kg, i.p
Foyet et al. BMC Complementary and Alternative Medicine  (2015) 15:333 Page 3 of 12
70 % ethanol between each animal to minimize odor
cues [25, 26].
Object recognition test
This test was performed as described by El-Marasy et al.
[27]. Briefly, three days before testing, each rat was
allowed to explore the apparatus for 2 min, while on the
testing day, 30 min following scopolamine injection, a ses-
sion of two trials, 2-min each was allowed. In the “sample”
trial (T1), two identical objects were placed in two oppos-
ite corners of the apparatus. A rat was placed in the appar-
atus and was left to explore these two identical objects.
After T1, the rat was placed back in its home cage and an
inter-trial interval of 1 h was given. Subsequently, the
“choice” trial (T2) was performed. In T2, a new object (N)
replaced one of the objects that were presented in T1,
then rats were exposed again to two different objects: the
familiar (F) and the new one (N). Exploration was defined
as follows: directing the nose toward the object at a dis-
tance of no more than 2 cm and/or touching the object
with the nose. From this measure, a series of variables
were then calculated: the total time spent in exploring the
two identical objects in T1, and that spent in exploring
the two different objects, F and N in T2.
The distinction between F and N in T2 was measured
by comparing the time spent in exploring the F with that
spent in exploring the N. DI is the dissimilarity index and
represents the difference in exploration time expressed
as a proportion of the total time spent exploring the
two objects in T2.
DI was then calculated using the following formula:
DI ¼ N−F
N þ F
Estimation of biochemical parameters
Brain tissue preparation
The rats were decapitated on day 14th after the last be-
havioral testing under chloroform anesthesia. The skull
was cut open and the brain was exposed from its dorsal
side. The whole brain was immediately removed and
cleaned with chilled normal saline on the ice. A 10 %
(w/v) homogenate of brain samples (0.03 M sodium
phosphate buffer, pH 7.4) was prepared. The homogen-
ate was centrifuged (15 min at 3000 rpm) and the super-
natant was used for assays of SOD, CAT activities, total
GSH content and MDA level. In addition, the levels of
AChE and ACh were estimated.
Estimation of antioxidant enzymes
Determination of SOD The activity of superoxide dis-
mutase (SOD) was assayed by monitoring its ability to
inhibit the photochemical reduction of nitroblue tetrazo-
lium (NBT). Each 1.5 mL reaction mixture contained
100 mM Tris/HCl (pH 7.8), 75 mM NBT, 2 M riboflavin,
6 mM EDTA, and 200 L of supernatant. Monitoring the
increase in absorbance at 560 nm followed the produc-
tion of blue formazan. One unit of SOD is defined as
the quantity required to inhibit the rate of NBT reduc-
tion by 50 % as described by Winterbourn et al. [28].
Estimation of GSH To measure the reduced glutathi-
one (GSH) level, the tissue homogenate (in 0.1 M phos-
phate buffer pH 7.4) was taken. The procedure was
followed as previously described by Shamnas et al. [29].
Briefly, the homogenate was added with equal volume of
trichloroacetic acid (TBA, 20 %) containing 1 mM
EDTA to precipitate the proteins. The mixture was kept
for 5 min prior to centrifugation. The supernatant
(200 μl) was then transferred to a new set of test tubes
and added 1.8 ml of the Ellman's reagent (5, 5'-dithio
bis-2-nitrobenzoic acid) (0.1 mM) was prepared in 0.3 M
phosphate buffer with 1 % of sodium citrate solution).
Then all the test tubes rose to the volume of 2 mL. After
the completion of the total reaction, the solutions were
measured at 412 nm against blank. Absorbance values
were compared with a standard curve generated from
standard curve from known GSH.
Determination of CAT Catalase (CAT) activity was
assayed following the method of Hritcu et al. [30]. The
reaction mixture consisted of 150 μL phosphate buffer
(0.01 M, pH 7.0), 100 μL supernatant. Reaction was
started by adding 250 μL H2O2 0.16 M, incubated at 37 °C
for 1 min and reaction was stopped by the addition of
1.0 mL of dichromate acetic acid reagent. The tubes were
immediately kept in a boiling water bath for 15 min while
the green color developed during the reaction and was
read at 570 nm on a spectrophotometer. Control tubes,
devoid of enzyme, were also processed in parallel.
The difference in absorbance per unit was used as the
measure of catalase activity.
Determination of MDA Malondialdehyde (MDA),
which is a measure of lipid peroxidation, was spectro-
photometrically measured using the thiobarbituric acid
assay [7, 31]. 200 μL of supernatant added and briefly
mixed with 1 mL of 50 % trichloroacetic acid in 0.1 M
HCl and 1 mL of 26 mM thiobarbituric acid. After the
vortex mixing, samples were maintained at 95 °C for
20 min. Furthermore, samples were centrifuged at
3000 rpm for 10 min and supernatants were read at
532 nm. A calibration curve was constructed using
MDA as standard and the results were expressed as
nmol/g protein.
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Estimation of brain neurotransmitter Estimation of
acetylcholinesterase (AChE) and Acetylcholine (Ach)
activities
Acetylcholinesterase activity was estimated by using an
artificial substrate, acetylthiocholine (ATC). In the
medium, thiocholine released due to the cleavage of
ATC by AChE is allowed to react with the -SH reagent
5,5’-dithiobis-2-nitrobenzoic acid (DTNB), which is re-
duced to a yellow colored anion called thionitrobenzoic
acid, measurable at the wave length 412 nm. Concentra-
tion of thionitrobenzoic acid was spectrophotometrically
detected and taken as a direct estimate of the AChE
activity [32]. Acetylcholine level in the whole brain was
estimated using Hydroxylamine method as described by
Stepankova et al. [33]. The reaction mixture was pre-
pared and mixed with the aqueous hydroxylamine
hydrochloride and 3.5 M aqueous KOH (1:1 v/v). The
resulting mixture was mixed 2 min. to convert ACh to-
tally to acethydroxamic acid. The pH value was changed
again by adding Conc. HCl/H2O (1:2 v/v). The reddish
brown color formed after adding 0.37 M ferric nitrate
was read at 540 nm. The Ach content was calculated
with reference to the standard values.
Statistical analysis
Data was presented as mean ± SEM. One-way ANOVA
(for Y-maze data) and two-way ANOVA (for novel object
recognition and Y-maze data followed by Bonferoni
Multiple Comparison Test was performed using
Graph Pad Prism version 5.00 for Windows, Graph Pad
Software, San Diego California USA. A probability level
of 0.05 or less was accepted as significant. Pearson’s
correlation coefficient and regression analysis were
used to evaluate the connection between behavioral re-
sponses and biochemical parameters.
Results
Effects of the extract in the Y-Maze task
In Y-maze task, the hydroalcoholic extract of E. coccinae
leaves significantly increased the spontaneous alternation
behavior in rats with cognitive deficit-induced by scopol-
amine after eight days administration compared to the
control group, (F (4, 12) = 3.25, P < 0.0102) (Fig. 1). Daily
oral administration of HEEC (200 and 400 mg/kg) for 14
consecutive days before scopolamine injection also sig-
nificantly increased the correct trials of rat in the Y-
maze compare to scopolamine non treated group sug-
gesting effects on short term-memory. Post-Hoc analysis
revealed no significant difference between the 2 groups
of extract. Also, post hoc analyses revealed significant
statistical differences (p < 0.0001) between animals ex-
posed to scopolamine and those treated with HEEC
(Fig. 1). Likewise, the HEEC (200 and 400 mg/kg) sub-
stantially reduced the number of line crossed in the Y-
maze (Fig. 2). However, this inhibition of the locomotory
activity was more pronounced at the dose of 200 mg/kg
and after 14 days of treatment (p < 0.0001) in compari-
son with the scopolamine-treated group. No significant
reduction in the ambulatory activity was noted with
piracetam.
Effects of the extract in the Novel object recognition
All rats treated with the hydroalcoholic extract from
leaves and piracetam, as well as the control animals took
more time to explore new object after 8 or 14 days of
treatment. However, the time taken by the animals sub-
jected to scopolamine injection was significantly less
than that of normal animals, indicating the impairment
of the memory process. The treatment of the animals by
Piracetam and HEEC (200 mg/kg) significantly amelio-
rated the exploratory time of the rats in this task as
Fig. 1 Effect of the hydroalcoholic extract of E. coccinae leaves and piracetam (Pir) on the spontaneous alternation percentage after 8 and
14 days of treatments on scopolamine (Scop) treated animal in Y-maze task. Each column represents mean ± S.E.M. of 6 animals. Data analysis
was performed using One way ANOVA followed by Bonferroni posttests. *P < 0.05; **P < 0.001; **P < 0.0001 vs. control animals; #P < 0.05 vs.
normal animals
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compared to scopolamine group (Fig. 3). Although
the exploratory time increased at the dose of 400 mg/kg,
this was not significant when compared to scopolamine
group. ANOVA of all differences yielded F (2, 38) = 4.034;
(p < 0.032). Discrimination Index data revealed a sig-
nificant effect of HEEC after 8 days (F (4, 18) = 2.92,
P < 0.0015) and after 14 days (F (3, 8) = 4.06, P < 0.0003)
of treatment. Post hoc comparisons indicated that the
HEEC 200 and 400 mg/kg-treated rats discriminated
significantly better N than F with respect to their
scopolamine-treated counterparts (P < 0.05, 8 days; and
P < 0.001, 14 days) (Fig. 4).
Effect of the hydroalcoholic extract of E. coccinae on brain
lipid peroxidation and antioxidant enzymes
Measurement of lipid peroxidation
As shown in Fig. 5a, pre-treatment with hydroalcoholic
extract of E. coccinae (200 and 400 mg/kg) for 14
successive days shows in a dose dependant manner
significantly reduction (F (3, 16) = 3.23, p < 0.00034) of
the MDA level in respect to the scopolamine treated
group. Post hoc analysis also showed a significant dif-
ference between scopolamine versus HEEC treated
group (p < 0.05). However the decrease in MDA level
of the piracetam and HEEC-treated group were still
below that of normal rats.
Effect of HEEC on Superoxide dismutase
When treated with scopolamine, the level of brain SOD
decreased significantly (p < 0.001) when compared with
that of normal animals. One way ANOVA followed by
post hoc test showed that the treatment of amnesic rats
with HEEC (200 and 400 mg/kg) significantly (F (4, 20) =
2.86, p < 0.00023) increased SOD level when compared to
scopolamine group (Fig. 5b). The standard drug piracetam
(150 mg/kg) also increased the SOD level but this was not
significant.
Fig. 2 Effect of the hydroalcoholic extract of E. coccinae leaves and piracetam (Pir) on the locomotory activity of animals in Y-maze task. Each
column represents mean ± S.E.M. of 6 animals. Data analysis was performed using One way ANOVA followed by Bonferroni posttests. *P < 0.05;
**P < 0.001; **P < 0.0001 vs. control animals; #P < 0.05 vs. normal animals
Fig. 3 Figure 3 Effect of MEEC and piracetam (Pir) on the exploration time of the familiar vs. the novel object in the object recognition test. Rats
received 14 daily administration of HEEC (200 mg/kg, p.o.), or donepezil (1.5 mg/kg, p.o.) used as a standard drug
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GSH activity in the brain
The effect of hydroalcoholic extract of HEEC on glutathi-
one content in the brain is summarized in Fig. 5c. The
GSH level of brain homogenate in scopolamine group
(1.54 ± 0.27) was found to be significantly lower (p < 0.01)
than the GSH level in normal group (2.78 ± 0.21). At
the end of the treatment period with HEEC (200 and
400 mg/kg) or piracetam (150 mg/kg), GSH level was
found to be increased in a highly significant manner
(P < 0.05, 400 mg/kg; P < 0.001, piracetam). Piracetam
Fig. 4 Effect of HEEC discrimination index (DI) of scopolamine-induced memory impairment in rats in the object recognition test. Rats received
14 daily administration of HEEC (200 and 400 mg/kg, p.o.) or Piracetam (150 mg/kg, i.p.) used as a standard drug
Fig. 5 Effect of the hydroalcoholic extract of E. coccinae administration on MAD (a) SOD (b), GSH (c) and CAT (C) level of the brain tissue. Data
was analyzed by one-way ANOVA followed by Bonferroni post-hoc test. Each column represents mean ± S.E.M. of 6 animals. ***p < 0.001, **p < 0.01
and *p < 0.05 when compared to scopolamine treated group; ###p < 0.001, when compared to normal animals
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almost completely restored the glutathione level in
scopolamine treated groups to the normal level.
CAT activity in the brain
As shown in Fig. 5d, scopolamine injection to the rats
brings to highly significant reduction (p < 0.001) in CAT
level in the rats brain. The treatment of the scopolamine
injected rats with the plant extract resulted in a signifi-
cant and dose dependent increase in catalase activity
when compared with Scopolamine injected rats.
More importantly, a significant positive correlation was
evidenced by determination of the linear regression
between SOD vs. spontaneous alternation (r = 0.75,
p < 0.0002) (Fig. 6a) and CAT vs. spontaneous alternation
(r = 0.80, p < 0.0002) (Fig. 6d) in scopolamine exposed
groups treated with the hydroalcoholic extract of E.
coccinae (200 mg/kg). The correlation between GSH vs.
spontaneous alternation was positive but very weak
(r = 0.51, p = 0.017) (Fig. 6c) while significant negative
correlation was obtained between MDA and spontaneous
alternation percentage (r = 0.54, p = 0.0073) (Fig. 6a).
Effect of hydroalcoholic extracts of E. coccinae on brain
AChE and Ach activities
The effect of hydroalcoholic extracts of E. coccinae in
brain AChE and Ach activities are shown in Fig. 5. Sco-
polamine administration resulted in significant increase
in the AChE activity with respect to Normal group).
Meanwhile, hydroalcoholic extracts of E. coccinae signifi-
cantly (F (2, 86) = 6.04, p < 0.0023) reduced AChE activity
reaching similar values to normal group (Fig. 6). These re-
sults show that administration of HEEC suppressed the
increase of AChE activity by scopolamine administration.
At the same time, was notice a significant decrease in
the Ach content in the brain of scopolamine treated
rats (Fig. 7). One way ANOVA analysis revealed that in
contrast to the Ach reduction, the rats treated with HEEC
and piracetam shows a significant recovery (F (2, 86) =
4.22, p < 0.012) on Ach content in the brain region. How-
ever with the Bonferroni's Multiple Comparison post Test,
this recovery was significant (P <0.05) only with the HEEC
at the dose of 200 mg/kg.
Discussion
In this report, we demonstrate that sub chronic treat-
ment with HEEC improved learning and memory behav-
iors in adult male rats subject to scopolamine memory
disruption. Specifically, we have shown that the oral ad-
ministration of HEEC (200 and 400 mg/kg) after 8 and
14 days ameliorated the memory retention in the novel
object recognition task and improved spatial learning in
the Y-maze. Acetylcholine is a neurotransmitter acting
on cholinergic receptors and widely distributed through-
out the brain. During the last decade, it has long re-
ceived much attention in memory research among
neuroscientist. It is well established that alteration in the
Fig. 6 Correlation between spontaneous alternation percentage vs. MDA (a), spontaneous alternation percentage vs. SOD (b), spontaneous
alternation percentage vs. GSH (c) and spontaneous alternation percentage vs. CAT (d) in the hydroalcoholic extract-treated groups (200 mg/kg);
with the 95 % confidence band of the best-fit line
Foyet et al. BMC Complementary and Alternative Medicine  (2015) 15:333 Page 8 of 12
levels of acetylcholine or AChE activity may affect the
cholinergic transmission process and leads to learning
and memory a deficit which imitates Alzheimer’s disease
[34]. Scopolamine, a nonselective muscarinic antagonist
block cholinergic signaling and produce memory and
cognitive dysfunctions, causing learning and memory
deficits including long-term and short term memory im-
pairment [35]. Consequently, intraperitoneal administra-
tion of the muscarinic antagonist scopolamine was widely
and successfully exploited as a pharmacological model for
AD in rats. Scopolamine induces dysregulation of the cho-
linergic neuronal pathway and memory circuits in the
central nervous system, resulting in serious impairments
in learning, acquisition, and short-term retention of spatial
memory tasks [36].
In the present study we used two well-characterized
memory tasks: Y-maze and novel object recognition to
evaluate the effect of the HEEC on the scopolamine
model of AD in rats. Spontaneous alternation behavior
determined using the Y-maze test has been viewed as an
indicator of spatial short-term memory [30]. In this test,
rats must remember the arm most recently entered in
order to alternate arm choice. Furthermore, treatment
with scopolamine has been demonstrated to impair
spontaneous alternation behavior in animal models [37].
In the present study, spontaneous alternation behavior
in scopolamine treated rats was significantly lower than
in rats treated with vehicle. In contrast, HEEC significantly
reversed the cognitive deficit induced by scopolamine in
the Y-maze task. Together, these results suggest that that
HEEC enhance short term or working memory. In the
same behavioral task, in contrast with piracetam, the
hydroalcoholic extract of E. coccinae, especially at the dose
of 400 mg/kg, significantly decreased the number of lines
crossed by the rats (ambulatory activity). It is somehow
difficult to evaluate the motor activity of the extract
with some variety of locomotory manifestations. In
our previous experiment using the same extract at
the same doses [16], the motor activity (number of
lines crossed) in the open field was decreased with an
increase of the time spent at the center of the maze
as compared to control. At the same time on the
EPM platform, locomotor index- number of entrance
in the closed arms decreased in the extract, as com-
pared to control. The correlation of anxiety and
memory parameters could thus be relevant since rats
were displayed lower anxiety when treated with HEEC
(200 and 400 mg/kg). So the increased activity in Y-maze
may be mainly due to memory facilitation by the HEEC,
resulting in increased searching in the maze and the better
spatial memory that we observed.
The novel object recognition test measures the natural
propensity of a rat to explore a novel versus familiar ob-
ject. Our results showed that exploration of the novel
object was reduced in animals exposed to intraperitoneal
injection with scopolamine. This task has both an ex-
ploratory behavior component as well as a memory re-
tention component such that an animal must have
sufficiently explored the familiar object during the pre-
test phase in order to distinguish between it and a novel
object later during the test phase [38]. In this study,
scopolamine-treated animals exhibited less total explor-
ation time during pre-training than normal animals. This
is similar to previous findings in other behavioral para-
digms showing that scopolamine-treated adult animals
exhibit decreased exploratory behavior and significantly
reduction in the discrimination index in the NOR task.
After the pre-treatment by HEEC, two-way analysis of
variance followed by Bonferroni post test revealed a sig-
nificant effect of the treatment on the total amount of
time spent exploring the novel objects as well as on the
discrimination index compare to scopolamine group. This
indicate that the extract sustain memory formation in rats
injected with scopolamine-induced dementia rat model.
Fig. 7 The effect of 14 days oral administration of the hydroalcoholic extract of E. coccinae (HEEC, 200 and 400 mg/kg) and piracetam (Pir, 150 mg/kg)
on AChE and Ach activity in rat’s brain
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Cholinergic transmission generally ends by the acetyl-
choline hydrolysis through the enzyme AChE which is
responsible for degradation of Acetylcholine to acetate
and choline at the level of the synaptic cleft. In this way,
AD has also been correlated with the loss of cholinergic
neurons and decreases in the levels of acetylcholine (ACh)
and choline acetyltransferase (ChAT) [39]. Lesions in
these pathways result in decreased Ach release and thus
cause learning and memory dysfunction. Until now, inhib-
ition of acetylcholinesterase (AChE) has served as a strat-
egy for the treatment of AD, senile dementia, ataxia, and
Parkinson’s disease [40, 41].
Thus, estimating the acetylcholine esterase activity can
provide valuable information on cholinergic function,
which can correlate with cognitive function. In that way,
AChE inhibitors play an important role in the nervous
system disorders, owing to their potential as pharmaco-
logical and toxicological agents. Recently, some AChE
inhibitors like tacrine and rivastigmine were used in the
treatment of Alzheimer’s disease [9].
Our results clearly indicated that the administration of
scopolamine to experimental animals was followed by a
significant increase in the AChE activity in the brain, es-
pecially in normal rats. The administration of the plant
extract for two weeks decreased acetylcholine esterase
activity in brain homogenate of rat subject to scopolam-
ine memory impairment. As a result, there was an in-
crease of Ach Expression in brain hence triggering of
cholinergic firings. This may be one of the mechanisms
explaining the ability of the HEEC to enhance memory
and cognition in this study. In present study, HEEC sig-
nificantly decreased the AChE levels in the rat whole
brain homogenate, indicating its potential in the attenu-
ations of severity of AD. However, an absolute conclu-
sion can’t be made on the AChE inhibitory effect of this
extract since the effect of extract alone on AChE activity
was not measured in this study.
In the scopolamine-induced AD animal model, the
well-replicated amnesic effect of scopolamine has been
identified as a principal consequence of the blockade of
post-synaptic muscarinic M1 transmission, leading to
disruption in the functioning of the hippocampus in
working memory [36]. Other suggested mechanism is
the increased oxidative stress in brains by scopolamine,
inducing the activation of a cascade of redox-sensitive
cell signal pathways [42]. Brain cells are known to con-
tain a very high percentage of long chain polyunsatur-
ated fatty acids. ROS are continuously generated in the
nervous system during normal metabolism and normal
neural activity. The brain is regularly subject to free
radical-induced lipid peroxidation. It is also known that
the protective system in the brain is poor against oxidative
stress, compared to other tissues [43]. In this way, the esti-
mation of the lipid peroxidation end product is commonly
used as the biomarkers for in vivo lipid peroxidation in
neurodegeneration research [44].
The results of antioxidant study showed decreased levels
of SOD, CAT, and GSH in the scopolamine-induced de-
mentia rat compared to normal rats. The protective system
of the organism against reactive oxygen species is very
complex, including enzymatic and non enzymatic bio-
logical process. These include SOD, that catalyses the con-
version of superoxide radicals to hydrogen peroxide, which
is then converted into water by GPX and catalase [45].
After 8 and 14 days pretreatment of the scopolamine-
induced dementia rat with the hydroalcoholic extract of
E. coccinae (200 and 400 mg.kg), there was a significant
improvement of the levels of SOD, CAT and GSH
whereas MDA level was decreased significantly. These
results suggest that the plant extract has an in vivo anti-
oxidant activity and is capable of ameliorating the effect
of ROS in the brain of rats.
In a previous study, we reported that the methanolic
extract of E. coccinae asper leaves improved spatial
memory in rat through a mechanism that involved anti-
oxidant and neuroprotective activities. Furthermore, we
observed that this extract was able to reduce iron (Fe3+)
into Fe2+ using and scavenged 2, 4-dinitrophenyl-1-
picryl hydrazyl (DPPH) radical in vitro [16]. This give us
more confidence to conclude that the attenuation of the
scopolamine neurotoxicity by the hydroalcoholic extract
of E. coccinae in the present study may be due to the
antioxidant propensity of this extract in the brain tissue.
Despite these interesting results of the neuroprotective
activity of HEEC, limitations of this work are that the
AChE activity of the extract and histopathological stud-
ies of frontal lobes and hippocampus were not mea-
sured. This will be the main goal of our upcoming
investigations.
Conclusion
The present study demonstrates the beneficial effect of
the hydroalcoholic extract of E. coccinae on scopolamine-
induced cognitive impairment. In this way, E. coccinae
protected from memory deficiency induced by scopolam-
ine, as shown by behavioral tests using the Y-maze and
Novel object recognition tests. Also, based on the results
of the biochemical studies, it can be concluded that E. coc-
cinae is an antioxidant; suggesting that it is possible the
protective effects were related to its antioxidant effects.
Although our results indicate that extract can ameliorate
scopolamine induced AChE activity increment, we cannot
say with great confidence that the extract has inhibitory
effects on the enzyme because the effect of extract alone
on AChE activity was not measured. Moreover, a sig-
nificant positive correlation between SOD vs. spontaneous
alternation and between CAT vs. spontaneous alternation
was found when linear regression was performed. However,
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supplementary pharmacological and phytochemical investi-
gations are necessary to clarify the molecular mechanisms
of neuroprotection for these herbal extracts, as well as the
principal bio-ingredient.
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